Atlas Trials

Neuroendocrine Tumours (NET)

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Neuroendocrine Tumours (NET)

RecordFirmDate
Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). (NCT06607692)Fundación de investigación HM2024-09-20
United Kingdom (UK) Patient Preference Study of Somatuline Autogel and Treatment Administration Setting (NCT04649580)Ipsen2021-04-27
A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumours (NCT04525638)Fundación de investigación HM2020-06-29

Track Neuroendocrine Tumours (NET) automatically

Every clearance here is in the API, with alerts when new ones post.